Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:MRK
Merck
|
131.19 | -10,02% | 3,18% | 332.278,86 | 2,35% | -19,03% |
|
NYSE:TMO
Thermo Fisher Scientific
|
595.30 | -17,43% | -8,17% | 227.235,73 | 0,26% | 14,15% |
|
SWX:NOVN
Novartis
|
93.37 | 8,15% | 21,52% | 190.512,74 | 3,56% | 4,67% |
|
SWX:LONN
Lonza Group
|
529.20 | -28,51% | -13,47% | 38.164,1 | 0,76% | 0,68% |
|
NYSE:BIO
Bio-Rad Laboratories Inc
|
293.85 | 82,36% | 111,21% | 7.921,7 | 0% | 15,07% |
|
SEHK:1548
Genscript Biotech
|
12.38 | -.278,84% | -49% | 26.295,77 | 0% | 0% |
|
NasdaqGS:PGEN
Precigen
|
1.38 | 0% | 0% | 345,81 | 0% | 0% |
|
NasdaqGM:HBIO
Harvard Bioscience
|
3.37 | 56,13% | 114,29% | 162,83 | 0% | -6,89% |
|
NasdaqCM:APDN
Applied DNA Sciences
|
2.51 | 0% | 0% | 2,17 | 0% | 0% |
